Last reviewed · How we verify

NCT06617195

Mechanisms of Anabolic Resistance in Older Humans

Recruiting now Last updated 21 January 2026
What this trial tests

trial testing Exercise in Aging in 120 participants. Currently enrolling.

Timeline
14 January 2025
Primary endpoint
16 September 2028
16 September 2030

Quick facts

Lead sponsorMayo Clinic
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date14 January 2025
Primary completion16 September 2028
Estimated completion16 September 2030
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 21 to 85, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to understand how chronic inflammation affects muscle function and responses to exercise in older adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06617195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing